The EU medical regulator will review Eli Lilly this week, according to a meeting agenda posted on its website on Monday (link)LLYApproved anti-diabetic and obesity drug Mounjaro when used preloaded in a multi-dose injection pen.

The U.S. drugmaker received EU approval for its once-weekly shot of Mounjaro late last year and has initially rolled out starting doses in vials in member countries Germany and Poland so patients need to pump the drug in before injecting it. syringe.

Eli Lilly's "Kwikpen," a multi-dose injection device that allows for four weekly subcutaneous injections, will be considered as a new route of administration for Mounjaro at the European Medicines Agency expert panel meeting, according to the agenda.

Eli Lilly has previously said the pen injector could win European approval by the middle of this year (link).

The UK last week became the first major market for the launch of Mounjaro, (link) a four-week Kwikpen.